Novo Nordisk cuts weight loss drug prices amid competition from rivals
Published
Danish group beats expectations with first-quarter sales up 24% and raises annual forecast on high demand
Full ArticlePublished
Danish group beats expectations with first-quarter sales up 24% and raises annual forecast on high demand
Full ArticleLatest Weight-Loss Drug , Faces Shortages .
The United States Food and Drug Administration
(FDA) says that high demand..
Novo Nordisk is under pressure to cut US prices of its weight loss drug, as demand soars.